Detalhe da pesquisa
1.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055253
2.
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 403(10434): 1341-1350, 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521086
3.
Top advances of the year: Cervical cancer.
Cancer
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651760
4.
How far is too far? Cancer prevention and clinical trial enrollment in geographically underserved patient populations.
Gynecol Oncol
; 184: 8-15, 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271774
5.
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.
Gynecol Oncol
; 186: 61-68, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603953
6.
Top advances of the year: Cervical cancer.
Cancer
; 129(5): 657-663, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609769
7.
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Gynecol Oncol
; 172: 82-91, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001446
8.
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
Gynecol Oncol
; 178: 161-169, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890345
9.
Overcoming disparities to improve cancer care: The story of cervical cancer.
Cancer
; 128(23): 4052-4054, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239012
10.
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.
Gynecol Oncol
; 161(2): 512-515, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33610319
11.
Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(7): 957-968, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553118
12.
Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
Cancer
; 126(22): 4948-4956, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910478
13.
Validation of the surprise question in gynecologic oncology: A one-question screen to promote palliative care integration and advance care planning.
Gynecol Oncol
; 157(3): 754-758, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171568
14.
A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer.
Gynecol Oncol
; 156(1): 13-22, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31708167
15.
Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer.
Gynecol Oncol
; 153(3): 555-561, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929823
16.
Emerging biomarkers in ovarian granulosa cell tumors.
Int J Gynecol Cancer
; 29(3): 560-565, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30833441
17.
Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers.
Gynecol Oncol
; 150(2): 338-342, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29935911
18.
Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review.
Gynecol Oncol
; 149(2): 394-400, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29472016
19.
Opioid use in gynecologic oncology in the age of the opioid epidemic: Part II - Balancing safety & accessibility.
Gynecol Oncol
; 149(2): 401-409, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29544707
20.
Androgen Receptor Expression in Endometrial Carcinoma.
Int J Gynecol Pathol
; 37(2): 167-173, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28582344